Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Dec;96(6):2702–2710. doi: 10.1172/JCI118337

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.

L B Schwartz 1, K Sakai 1, T R Bradford 1, S Ren 1, B Zweiman 1, A S Worobec 1, D D Metcalfe 1
PMCID: PMC185977  PMID: 8675637

Abstract

Tryptase, a protease produced by all mast cells, was evaluated as a clinical marker of systemic mastocytosis. Two sandwich immunoassays were evaluated, one which used the mAb G5 for capture, the other which used B12 for capture. The B12 capture assay measured both recombinant alpha- and beta-tryptase, whereas the G5 capture assay measured primarily recombinant beta-tryptase. G5 binds with low affinity to both recombinant alpha-tryptase and tryptase in blood from normal and nonacute mastocytosis subjects, and binds with high affinity to recombinant beta-tryptase, tryptase in serum during anaphylaxis, and tryptase stored in mast cell secretory granules. B12 recognizes all of these forms of tryptase with high affinity. As reported previously, during systemic anaphylaxis in patients without known mastocytosis, the ratio of B12- to G5-measured tryptase was always < 5 and approached unity (Schwartz L.B., T.R. Bradford, C. Rouse, A.-M. Irani, G. Rasp, J.K. Van der Zwan and P.-W.G. Van der Linden, J. Clin. Immunol. 14:190-204). In this report, most mastocytosis patients with systemic disease have B12-measured tryptase levels that are elevated (> 20 ng/ml) and are at least 10-fold greater than the corresponding G5-measured tryptase level. Most of those subjects with B12-measured tryptase levels of < 20 ng/ml had only cutaneous manifestations. The B12 assay for alpha-tryptase and beta-tryptase, particularly when performed in conjunction with the G5 assay for beta-tryptase, provides a more precise measure of mast cell involvement than currently available assessments, a promising potential screening test for systemic mastocytosis and may provide an improved means to follow disease progression and response to therapy.

Full text

PDF
2702

Images in this article

2706Image
on p.2706
2706Image
on p.2706
2707Image
on p.2707

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austen K. F. Systemic mastocytosis. N Engl J Med. 1992 Feb 27;326(9):639–640. doi: 10.1056/NEJM199202273260912. [DOI] [PubMed] [Google Scholar]
  2. Castells M. C., Irani A. M., Schwartz L. B. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987 Apr 1;138(7):2184–2189. [PubMed] [Google Scholar]
  3. Enander I., Matsson P., Nystrand J., Andersson A. S., Eklund E., Bradford T. R., Schwartz L. B. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods. 1991 Apr 8;138(1):39–46. doi: 10.1016/0022-1759(91)90062-k. [DOI] [PubMed] [Google Scholar]
  4. Granerus G., Lönnqvist B., Roupe G. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis. Agents Actions. 1994 Jun;41(Spec No):C127–C128. doi: 10.1007/BF02007796. [DOI] [PubMed] [Google Scholar]
  5. Huang R., Abrink M., Gobl A. E., Nilsson G., Aveskogh M., Larsson L. G., Nilsson K., Hellman L. Expression of a mast cell tryptase in the human monocytic cell lines U-937 and Mono Mac 6. Scand J Immunol. 1993 Oct;38(4):359–367. doi: 10.1111/j.1365-3083.1993.tb01738.x. [DOI] [PubMed] [Google Scholar]
  6. Irani A. A., Garriga M. M., Metcalfe D. D., Schwartz L. B. Mast cells in cutaneous mastocytosis: accumulation of the MCTC type. Clin Exp Allergy. 1990 Jan;20(1):53–58. doi: 10.1111/j.1365-2222.1990.tb02775.x. [DOI] [PubMed] [Google Scholar]
  7. Irani A. A., Schechter N. M., Craig S. S., DeBlois G., Schwartz L. B. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4464–4468. doi: 10.1073/pnas.83.12.4464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Irani A. M., Craig S. S., DeBlois G., Elson C. O., Schechter N. M., Schwartz L. B. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol. 1987 Jun 15;138(12):4381–4386. [PubMed] [Google Scholar]
  9. Metcalfe D. D. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol. 1991 Mar;96(3):2S–4S. [PubMed] [Google Scholar]
  10. Metcalfe D. D. The treatment of mastocytosis: an overview. J Invest Dermatol. 1991 Mar;96(3):55S–59S. [PubMed] [Google Scholar]
  11. Miller J. S., Moxley G., Schwartz L. B. Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest. 1990 Sep;86(3):864–870. doi: 10.1172/JCI114786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Miller J. S., Westin E. H., Schwartz L. B. Cloning and characterization of complementary DNA for human tryptase. J Clin Invest. 1989 Oct;84(4):1188–1195. doi: 10.1172/JCI114284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nagata H., Worobec A. S., Oh C. K., Chowdhury B. A., Tannenbaum S., Suzuki Y., Metcalfe D. D. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10560–10564. doi: 10.1073/pnas.92.23.10560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schwartz L. B., Bradford T. R., Lee D. C., Chlebowski J. F. Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Production of monoclonal antibodies recognizing active tryptase. J Immunol. 1990 Mar 15;144(6):2304–2311. [PubMed] [Google Scholar]
  15. Schwartz L. B., Bradford T. R., Rouse C., Irani A. M., Rasp G., Van der Zwan J. K., Van der Linden P. W. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol. 1994 May;14(3):190–204. doi: 10.1007/BF01533368. [DOI] [PubMed] [Google Scholar]
  16. Schwartz L. B., Irani A. M., Roller K., Castells M. C., Schechter N. M. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987 Apr 15;138(8):2611–2615. [PubMed] [Google Scholar]
  17. Schwartz L. B., Metcalfe D. D., Miller J. S., Earl H., Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987 Jun 25;316(26):1622–1626. doi: 10.1056/NEJM198706253162603. [DOI] [PubMed] [Google Scholar]
  18. Schwartz L. B. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. J Immunol. 1985 Jan;134(1):526–531. [PubMed] [Google Scholar]
  19. Smith C. H., Kepley C., Schwartz L. B., Lee T. H. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol. 1995 Sep;96(3):360–364. doi: 10.1016/s0091-6749(95)70055-2. [DOI] [PubMed] [Google Scholar]
  20. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  21. Vanderslice P., Ballinger S. M., Tam E. K., Goldstein S. M., Craik C. S., Caughey G. H. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A. 1990 May;87(10):3811–3815. doi: 10.1073/pnas.87.10.3811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Xia H. Z., Kepley C. L., Sakai K., Chelliah J., Irani A. M., Schwartz L. B. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol. 1995 May 15;154(10):5472–5480. [PubMed] [Google Scholar]
  23. Ziegler-Heitbrock H. W., Thiel E., Fütterer A., Herzog V., Wirtz A., Riethmüller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer. 1988 Mar 15;41(3):456–461. doi: 10.1002/ijc.2910410324. [DOI] [PubMed] [Google Scholar]
  24. van der Linden P. W., Hack C. E., Poortman J., Vivié-Kipp Y. C., Struyvenberg A., van der Zwan J. K. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol. 1992 Jul;90(1):110–118. doi: 10.1016/s0091-6749(06)80017-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES